A recent study reveals that patients who come off blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Findings released in a major health publication demonstrates that while obese people frequently drop a large proportion of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.
"Users using such medications should be cognizant of the potential of fast rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain suggests a return to pre-treatment mass in about one and a half years.
Weighing Approaches
The analysis, which examined dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with other pills.
Researchers point out that people who lose weight through diet and exercise usually have a slower creep back—perhaps 0.1 kg a month—post-intervention.
Explaining the Quick Rebound
Nutrition scientists propose the mechanism of the injections explains the amplified weight return.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of GLP-1 concentrations far above than normal may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication means appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Disease?
The NHS advise the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals say that, considering the likelihood of weight regain, the therapy should be considered long-term.
This perspective is supported by pharmaceutical companies, who state that the results "emphasize the chronic character of obesity," akin to managing conditions like diabetes.
User Experiences
People who have stopped the medication explain a powerful resurgence of hunger.
"It was like something flipping and you're instantly extremely hungry," recalled one woman.
This challenge is compounded if patients have not developed sustainable lifestyle or habit changes during therapy.
Significant Interest
Figures show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is higher among women than men.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are potent tools for shedding pounds, they are not a standalone solution and lasting health benefits hinges on combined lifestyle changes.
